Comparison · NCT04092257-5115824d
HIV Positive vs HIV Negative: High Risk (hr)-Human Papillomavirus (HPV) Positive Rate
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. HIV Positive vs HIV Negative: High Risk (hr)-Human Papillomavirus (HPV) Positive Rate. Trial comparisons, record NCT04092257-5115824d. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04092257-5115824d
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.472 | 0.433 | 0.511 | wilson | |
| Risk in group 2 | 0.29 | 0.255 | 0.326 | wilson | |
| Risk difference, group 1 minus group 2 | 0.182 | 0.129 | 0.234 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.63 | 1.41 | 1.89 | log | |
| Odds ratio, group 1 over group 2 | 2.19 | 1.74 | 2.77 | log | |
| Number needed to treat, for one more participant with the outcome on HIV Positive than on HIV Negative | 5.48 | 4.27 | 7.76 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | HIV Positive | Women living with HIV | 295 | 625 | OG000 |
| Group 2 | HIV Negative | Women living without HIV | 181 | 625 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- High Risk (hr)-Human Papillomavirus (HPV) Positive Rate
- Description
- The proportion of women who tested High risk (hr)-human papillomavirus (HPV) positive on a self-collected vaginal brush among enrolled participants.
- Time frame
- Baseline
- Population
- Participants joined the study and provided self-collected vaginal samples using a Viba-Brush® for HPV testing.
Source ClinicalTrials.gov
Trial
- Title
- HPV-Based Screen-and-Treat Demonstration Project in Lilongwe
- NCT number
- NCT04092257
- Phases
- NA
- Conditions
- HPV Infection, Cervical Cancer, HIV Infections
- Interventions
- VIA and thermocoagulation
- Lead sponsor
- UNC Lineberger Comprehensive Cancer Center
- Results first posted
- 2025-08-06
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT04092257?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT04092257-5115824d